# Innovation1 Biotech Inc. (IVBT)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/IVBT/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2024 | $ 0 | $ -304.8K | $ -155.9K | $ 605.1K | $ -3.34M |
| 2023 | $ 113.4K | $ -6.07M | $ -622.7K | $ 464.6K | $ -3.05M |
| 2022 | $ 0 | $ -46.10M | $ -3.58M | $ 32.4K | $ 1.48M |
| 2021 | $ 3.7K | $ 1.23M | $ -886.5K | $ 10.0K | $ 44.05M |
| 2020 | $ 274.5K | $ -3.25M | $ -375.9K | $ 921.7K | $ -2.93M |
| 2019 | $ 101.6K | $ -449.8K | $ -462.3K | $ 204.4K | $ -250.1K |
| 2018 | $ 16.9K | $ -1.38M | $ -1.25M | $ 49.5K | $ 71.9K |
| 2017 | $ 6.9K | $ -62.8K | $ -66.0K | $ 10.0K | $ -49.1K |
| 2016 | $ 0 | $ -53.9K | $ -55.3K | $ 0 | $ -56.1K |
| 2015 | $ 0 | $ -23.3K | $ -18.9K | $ 0 | $ -20.9K |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | -0.18 |
| Liabilities / Eq | -1.04 |
| Current Ratio | 0.04 |

## Other views

- [Metrics](https://sponda.capital/en/IVBT.md)
- [Charts](https://sponda.capital/en/IVBT/charts.md)
- [Compare](https://sponda.capital/en/IVBT/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-27.